'The Last Smile', directed by Shankey Srinivasan, is the story of Amit Zutshi -- the son of the film's producer Jeevan Zutshi -- who died in 2008.
"The movie was produced with the sole purpose of educating the masses about the dangers and life threatening impact of taking unregulated supplements that are available over the counters in the US," Zutshi told PTI in an interview.
"The last smile of my son Amit, three days before his passing on March 19, 2008, due to the dangerous unregulated supplements will never die, through Amit Zutshi Foundation, my book and movie The Last Smile as a tribute to him and as a vehicle to save other lives," Zutshi said, before leaving for Italy this week.
Based on Zutshi's book with the same title, the movie was screened at Capitol Hill early this year which was attended by several lawmakers and influential Congressional aides. It was officially screened by Cinequest Film Festival on March 10, voted Best Film Festival by USA Today, for its world premiere.
After the unfortunate death of his son Amit, Zutshi has
been single-handedly running a campaign against unregulated drugs --- talking to lawmakers and convincing the government to initiate action against manufacturers of dietary supplements.
As a result, the Justice Department itself has taken action against more than 100 makers and marketers of dietary supplements.
The New York State Attorney has asked four major retailers - Walmart, GNC, Target and Walgreens - to cease sale of their store branded herbal supplements as they do not contain the herbs purportedly listed on their labels.
From Italy, Zutshi is headed to India, where he plans to screen his movie.
"It is very important to raise awareness about it in India," he said. "I have paid a very heavy price because of this. My life changed forever because of these evil manufacturers and dealers of these unregulated supplements."
In the US, as many as 23,000 people end up in hospitals every year due to dietary supplements, Zutshi said referring to a study.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
